• Exchange: Venture
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cynapsus Therapeutics Inc

+ Add to Watchlist

CTH:CN

0.8500 CAD 0.00000.00%

As of 15:38:39 ET on 10/24/2014.

Snapshot for Cynapsus Therapeutics Inc (CTH)

Open: 0.8400 Day's Range: 0.8300 - 0.8600 Volume: 50,550
Previous Close: 0.8500 52wk Range: 0.3550 - 1.5100 1-Yr Rtn: +112.50%

Stock Chart for CTH

No chart data available.
  • CTH:CN 0.8500
  • 1D
  • 1M
  • 1Y
0.8500
Interactive CTH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CTH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.1100
Est. EPS (CAD) (12/2014) -0.1800
Est. PEG Ratio -
Market Cap (M CAD) 67.12
Shares Outstanding (M) 78.97
30 Day Average Volume 149,602
Price/Book (mrq) 3.2446
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CTH

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for CTH

Cynapsus Therapeutics, Inc. researches and develops pharmaceuticals. The Company researches treatments for Parkinson's disease, neuropathic pain associated with multiple sclerosis and cancer, and nausea and vomiting and appetite stimulation.

Anthony J GiovinazzoPresident/CEOAndrew Michael WilliamsCFO/COO
Thierry BilbaultExec VP:CMC/Chief Scientific Ofcr
More Company Profile & Key Executives for CTH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil